MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 05.11.2025
Charles River Laboratories International Kurzfristige Verbindlichkeiten 2011-2026 | CRL
Kurzfristige Verbindlichkeiten Jährlich Charles River Laboratories International
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 994 M | 1.06 B | 1.09 B | 1.03 B | 840 M | 710 M | 558 M | 464 M | 430 M | 312 M | 296 M | 247 M | 342 M | 217 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.09 B | 217 M | 614 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
372 M | $ 23.0 | 2.86 % | $ 248 M |  China |
 |
Castle Biosciences
CSTL
|
49.4 M | $ 39.93 | -1.67 % | $ 1.11 B | USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
DarioHealth Corp.
DRIO
|
12.5 M | $ 12.98 | 6.97 % | $ 368 M |  Israel |
 |
Fulgent Genetics
FLGT
|
72.9 M | $ 27.9 | -0.39 % | $ 844 M | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
BioNano Genomics
BNGO
|
37.3 M | $ 1.6 | -0.22 % | $ 2.03 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
Co-Diagnostics
CODX
|
5.75 M | $ 6.1 | 1.16 % | $ 179 M | USA |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Danaher Corporation
DHR
|
6.8 B | $ 234.99 | -0.25 % | $ 172 B | USA |
 |
DexCom
DXCM
|
1.56 B | $ 68.47 | -2.33 % | $ 26.4 B | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
Exact Sciences Corporation
EXAS
|
732 M | $ 101.77 | 0.14 % | $ 18.9 B | USA |
 |
Mettler-Toledo International
MTD
|
1.17 B | $ 1 461.94 | -0.56 % | $ 31 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
164 M | $ 6.63 | -0.08 % | $ 601 M | USA |
 |
CareDx, Inc
CDNA
|
78.1 M | $ 17.5 | -7.41 % | $ 941 M | USA |
 |
National Research Corporation
NRC
|
36.2 M | $ 19.66 | 4.02 % | $ 482 M | USA |
 |
Celcuity
CELC
|
31.7 M | $ 105.54 | -3.33 % | $ 4.16 B | USA |
 |
Natera
NTRA
|
310 M | $ 237.86 | -6.5 % | $ 23.4 B | USA |
 |
OPKO Health
OPK
|
193 M | $ 1.37 | 0.37 % | $ 951 M | USA |
 |
Anixa Biosciences
ANIX
|
2.5 M | $ 3.4 | 3.66 % | $ 108 K | USA |
 |
Guardant Health
GH
|
226 M | $ 107.75 | -1.98 % | $ 13.2 B | USA |
 |
Personalis
PSNL
|
31.1 M | $ 8.36 | -10.64 % | $ 495 M | USA |
 |
QIAGEN N.V.
QGEN
|
544 M | $ 48.19 | 1.71 % | $ 10.7 B |  Niderland |
 |
Aspira Women's Health
AWH
|
5.78 M | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
6.96 B | $ 243.4 | -0.36 % | $ 44.1 B | USA |
 |
Illumina
ILMN
|
1.55 B | $ 146.41 | -2.48 % | $ 23.3 B | USA |
 |
Thermo Fisher Scientific
TMO
|
13.3 B | $ 605.45 | -1.87 % | $ 231 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.17 B | $ 177.06 | -0.64 % | $ 19.7 B | USA |
|
Biodesix
BDSX
|
14.3 M | $ 5.77 | -3.27 % | $ 748 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
3.33 B | $ 254.76 | 0.43 % | $ 21.4 B | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
91.4 M | $ 34.81 | -4.76 % | $ 2.08 B | USA |
 |
ICON Public Limited Company
ICLR
|
2.8 B | $ 189.39 | -6.67 % | $ 15.6 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.07 B | $ 708.9 | -0.79 % | $ 58.5 B | USA |
 |
Lantheus Holdings
LNTH
|
241 M | $ 68.27 | -1.59 % | $ 4.72 B | USA |